Follow us on Twitter
Cardiac Arrhythmia patents
This page is updated frequently with new Cardiac Arrhythmia-related patents. Subscribe to the Cardiac Arrhythmia RSS feed to automatically get the update: related Cardiac RSS feeds.
|| List of recent Cardiac Arrhythmia-related patents
|Compositions for preventing cardiac arrhythmia|
Disclosed herein are compositions and methods for treating or preventing a cardiac arrhythmia in a subject.. .
|Treating long qt syndrome|
This document relates to compounds useful for treating cardiac arrhythmias, for example, long qt syndrome. Also provided herein are methods and materials for using such compounds to shorten myocardial repolarization time in a patient..
|Ablation targeting nerves in or near the inferior vena cava and/or abdominal aorta for treatment of hypertension|
A method for the treatment of a patient for the purpose of lowering blood pressure and/or treating other medical conditions such as cardiac arrhythmias. A catheter having an ablation element is placed inside the body of a patient and is directed to a targeted location either on in the abdominal aorta where the right or left renal arteries branch from the aorta at or near the superior junction or ostia or on the inside of the inferior vena cava near the junction with the right renal vein or in the left renal vein at a position spatially near where the left renal artery branches from the abdominal aorta.
|Devices, systems, and methods for treating cardiac arrhythmias|
Medical devices are described for performing mapping, ablating, and/or pacing procedures on one or more layers of the cardiac wall via an epicardial approach in a minimally invasive (e.g., orthoscopic) surgical procedure. One of the medical devices described includes a main support member and one or more secondary support members extending outwardly from the main support member having electrodes configured to receive electrical impulses.
|Sensing vector selection in a cardiac stimulus device with postural assessment|
Methods, implantable medical devices and systems configured to perform analysis of captured signals from implanted electrodes to identify cardiac arrhythmias. In an illustrative embodiment, signals captured from two or more sensing vectors are analyzed, where the signals are captured with a patient in at least first and second body positions.
|Method and apparatus for automatic arrhythmia classification with confidence estimation|
An arrhythmia classification system receives cardiac data from an implantable medical device, performs automatic adjudication of each cardiac arrhythmia episode indicated by the cardiac data, and generates episode data representative of information associated with the episode. The episode data include at least an episode classification resulting from the automatic adjudication of the episode and a confidence level in the episode classification.
|5-ht2c receptor agonists in the treatment of disorders ameliorated by reduction of norepinephrine level|
Uses of 5-ht2c receptor agonists in the treatment of disorders ameliorated by reduction of an individual's norepinephrine level, wherein said disorders include but are not limited to hypernorepinephrinemia, cardiomyopathy, cardiac hypertrophy, cardiomyocyte hypertrophy in post-myocardial infarction remodeling, elevated heart rate, vasoconstriction, acute pulmonary vasoconstriction, hypertension, heart failure, cardiac dysfunction after stroke, cardiac arrhythmia, metabolic syndrome, abnormal lipid metabolism, hyperthermia, cushing syndrome, pheochromocytoma, epilepsy, obstructive sleep apnea, insomnia, glaucoma, osteoarthritis, rheumatoid arthritis, and asthma.. .
|Coordinated his-bundle pacing and high energy therapy|
A cardiac arrhythmia can be identified, such as a tachycardia or fibrillation episode (atrial or ventricular). In responses to the detected arrhythmia, a coordinated electrostimulation therapy can be provided using at least one of a defibrillation shock therapy, a pre-shock conditioning therapy, or a post-shock conditioning therapy.
|Apparatus and method for identifying atrial arrhythmia by far-field sensing|
In a subcutaneous implantable cardioverter/defibrillator, cardiac arrhythmias are detected to determine necessary therapeutic action. Cardiac signal information is sensed from far field electrodes implanted in a patient.
|Methadone chiral isolate as an improved pharmaceutical|
The present invention relates to a method for treating drug addiction or neuropathic pain in a patient known to be vulnerable to life threatening cardiac arrhythmias (e.g., abnormally prolonged qt intervals, potassium chanelopathies, hypokalemia, or a combination thereof) by administering the r isolate of methadone to the patient.. .
|Treatment of cardiac arrhythmia utilizing ultrasound|
A noninvasive or minimally invasive treatment of cardiac arrhythmia such as supraventricular and ventricular arrhythmias, specifically atrial fibrillation and ventricular tachycardia, by treating the tissue with heat produced by ultrasound, including high intensity focused ultrasound or hifu. A transducer inside the body emits a pulse to assist in focusing the hifu pulse at the proper location to treat the desired tissue..
|Electrophysiology catheter with mechanical use limiter|
A catheter for the treatment of tissue, particularly for the treatment of cardiac tissue to alleviate cardiac arrhythmias includes a connector having mechanical use limiter that may be placed in the handle of the catheter or at any point along the electrical connection pathway to an electro-anatomic mapping system and/or ablation system. The mechanical use limiter has a counter wheel and locking pin which when engaged disables the reconnection of the connector to any mated connector after a predetermined number of uses..
|Prevention and treatment of cardiac arrhythmias|
Compositions of the invention, including compounds that bind to a receptor for a glucagon-like peptide-1, an incretin, a glucagon-like peptide-1 (glp-1), an exendin, or an agonist, an analog (preferably an agonist analog), a derivative, or a variant of any of aforementioned compounds, are used in the prevention and treatment of arrhythmias associated with cardiac ischemia, cardiac ischemia-perfusion and/or congestive heart failure. The invention relates to both the method and compositions for such treatment..
|Implants and methods for treating cardiac arrhythmias|
Devices and methods are described for treating maladies such as atrial fibrillation. The devices and methods, in some implementations, include implant comprising a ribbon or other structure formed into one or more rings.
|System and method for non-invasive treatment of cardiac arrhythmias|
A method for non-invasive treatment of cardiac arrhythmias is provided. The method includes acquiring body surface electrical signals at locations on a body surface of a living being from electrodes placed on locations of the body surface, reconstructing three-dimensional heart and torso anatomical models of the living being from an imaging scan, and calculating an electrical activity a throughout three-dimensional volume of the heart by electrocardiogram inverse problem solving based at least in part on the acquired body surface electrical signals and the reconstructed three-dimensional heart and torso anatomical models.
|Systems for detecting cardiac arrhythmias|
A system for calculating a variability value that is indicative of af by obtaining a signal sequence of a plurality of rr intervals by monitoring electrical activity of a patient's heart. Each rr interval is converted into an instantaneous heart rate value and sorted into ascending order.
|Energy delivery systems and uses thereof|
The present invention relates to comprehensive systems, devices and methods for delivering energy to tissue for a wide variety of applications, including medical procedures (e.g., tissue ablation, resection, cautery, vascular thrombosis, treatment of cardiac arrhythmias and dysrhythmias, electrosurgery, tissue harvest, etc.). In certain embodiments, systems, devices, and methods are provided for treating a tissue region (e.g., a tumor) through application of energy..
|System for cardiac arrhythmia detection and characterization|
A system for analyzing cardiac electrophysiological signals includes an acquisition processor for acquiring signal data representing heart electrical activity over multiple heart cycles. An individual heart cycle comprises a signal portion between successive sequential r waves.
|Alarm processor for detection of adverse hemodynamic effects of cardiac arrhythmia|
The disclosed embodiments relate to an apparatus and method for providing a warning. In one example, an apparatus includes a sensor, which is configured to be coupled to a body of a patient and to output a photoplethysmograph signal, which is indicative of pulse waveforms in the body.
|Compounds and their use as ikach blockers|
Or a pharmaceutically acceptable salt thereof, wherein m, n, r1, r2, r3, r4, r5, x and y are as defined herein. Compounds according to formula i are pharmacologically effective as potassium channel inhibitors, in particular inhibitors of the acetylcholine operated inward rectifying potassium channel current (i.e.
|Method of detecting and classifying arrhythmias|
A method of detecting and classifying cardiac arrhythmias, comprising: receiving a hemodynamic wave signal from at least one hemodynamic sensor by a processor; receiving a cardiac electrical wave signal from a cardiac stimulation device by the processor; integrating, by the processor, the received hemodynamic wave signal and the received cardiac electrical wave signal; determining if a heart arrhythmia is present via examination of the regularity of the hemodynamic signal; and if a heart arrhythmia is determined, classifying the arrhythmia according to a time correlation between the hemodynamic signal and the electrical signal.. .
|Energy delivery systems and uses thereof|
The present invention relates to comprehensive systems, devices and methods for delivering energy to tissue for a wide variety of applications, including medical procedures (e.g., tissue ablation, resection, cautery, vascular thrombosis, treatment of cardiac arrhythmias and dysrhythmias, electrosurgery, tissue harvest, etc.). In certain embodiments, systems, devices, and methods are provided for delivering energy to difficult to access tissue regions (e.g.
|Patient readable portable atrial fibrillation detector|
Systems and devices to gather data from a subject's heart, analyze said data to determine whether the subject is experiencing cardiac arrhythmia, and display results of said determining. Use, and display of cardiac condition information, are preferably simple and unambiguous to untrained users..
|Electrophysiology catheter handle having accessible interior|
A catheter for the treatment of tissue, particularly for the treatment of cardiac tissue to alleviate cardiac arrhythmias includes a handle housing a combination of steering components, electronic circuitry and/or infusion tubing. An interior notch in the handle around a circumference of the handle perpendicular to the longitudinal axis of the handle provides a means for access to the sealed handle in case a repair to the interior components is necessary during manufacture or reprocessing.
|Method and apparatus for classifying cardiac arrhythmia|
A method and a device for classifying cardiac arrhythmia, using an electrocardiogram (ecg) signal, are provided. The method includes receiving the ecg signal representing an electrical activity of a heart of an individual over a period of time, the ecg signal including ecg beats.
Popular terms: [SEARCH]
Cardiac Arrhythmia topics: Arrhythmia, Cardiac Arrhythmia, Arrhythmias, Cardiac Arrhythmias, Fibrillation, Medical Device, Implantable Medical Device, Epinephrine, Ventricular, Tachycardia, Atrial Fibrillation, Atrial Fib, Electrical Signal, Sleep Apnea, Rheumatoid Arthritis
Follow us on Twitter
This listing is a sample listing of patents related to Cardiac Arrhythmia for is only meant as a recent sample of applications filed, not a comprehensive history. There may be associated servicemarks and trademarks related to these patents. Please check with patent attorney if you need further assistance or plan to use for business purposes. This patent data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Cardiac Arrhythmia with additional patents listed. Browse our RSS directory or Search for other possible listings.